Did you know that almost half of pill users miss one or more pills per cycle?1 ORTHO EVRA® provided consistently better compliance than an OC comparator across all cycles and across all age groups.

Results from a clinical trial reported up to 97% perfect compliance vs an OC in nearly 6000 total cycles2
  • In a Phase III clinical study (N=1489), patch users had significantly more cycles with perfect compliance* and significantly fewer cycles with dosing errors than OC users (P<0.001)2

Study design: Randomized, open-label, North American comparative trial to determine compliance with the Patch overall by age, and to compare rates of perfect use with those of an established OC.

*Perfect compliance was defined as 21 consecutive days of drug followed by a 7-day drug-free period with no patch worn for more than 8 days.

    References:
  1. Rosenberg MJ, Waugh MS, Burnhill MS. Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation. Fam Plann Perspect. 1998;30:89-92, 104.
  2. Urdl W, Apter D, Alperstein A, et al, for the ORTHO EVRA/EVRA 003 Study Group. Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception. Eur J Obstet Gynecol  Reprod Biol. 2005;121:202-210.
  3. Archer DF, Bigrigg A, Smallwood GH, Shangold GA, Creasy GW, Fisher AC. Assessment of compliance with a weekly contraceptive patch (Ortho Evra™/Evra™) among North American women. Fertil Steril. 2002;77(suppl 2):S27-S31.